From the horse's mouth ( and not an email to friends) announced to the market less than a month ago in their April Investor Presentation..........
""Phase IIb trial (63 patients) for ovarian cancer patients after successful 1st or 2nd line therapy has completed recruiting patients in U.S. & Australia to:
–Assure comparability of multiple manufacturing centers
–Confirm safety & tolerability established in earlier trials
–Compare CVac to standard of care (progression-free survival)
–Confirm host immunologic response to CVac therapy
–Recruitment completed in September 2011
–Interim PFS Data in 2012
–Final PFS Data anticipated in 2013""
wednesday 9 may, page-7
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |